Thus, PDPN may present an opportunity to interrupt oncogenic signaling cascades that induce its expression such as those initiated by a number of tumor promoters including Ras [35, 36], FGF/BMP [78], Src [34], EGF [73], and TGFβ [79, 80]. The gene discussed is SRC; the disease is neoplasm.